[Form 4] a.k.a. Brands Holding Corp. Insider Trading Activity

Rhea-AI Filing Summary

Ilene Eskenazi, a director of A.K.A. Brands Holding Corp. (AKA), reported an insider sale of common stock. On 08/13/2025 she disposed of 2,749 shares at a price of $11.38 per share, leaving her with 18,163 shares beneficially owned. The Form 4 was signed by an attorney-in-fact on 08/15/2025. No derivative transactions or additional remarks were reported.

Positive

• None.

Negative

• Director sale disclosed: Ilene Eskenazi sold 2,749 shares at $11.38, reducing her holdings to 18,163 shares, which may be viewed as insider liquidity rather than support for the stock.

Insights

Financial Analyst

TL;DR: Routine insider sale by a director, modest in size relative to reported post-sale holdings.

The transaction shows a director-level sale of 2,749 shares at $11.38, reducing beneficial ownership to 18,163 shares. For investors, this is a straightforward disclosure of insider liquidity rather than a sign of operational change, because the filing contains no additional context such as planned sales or a Rule 10b5-1 plan.

Corporate Governance Expert

TL;DR: Compliance disclosure appears complete; sale was reported on Form 4 and signed by an authorized attorney-in-fact.

The Form 4 identifies the reporting person as a director and files as an individual report. The signature by an attorney-in-fact is properly recorded. There are no derivative positions disclosed and no amendments noted, indicating a routine, timely reporting of a common-stock disposition.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Eskenazi Ilene

(Last) (First) (Middle)

C/O A.K.A. BRANDS HOLDING CORP.

100 MONTGOMERY STREET, SUITE 2270

(Street)

SAN FRANCISCO CA 94104

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
A.K.A. BRANDS HOLDING CORP. [ AKA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/13/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, $0.001 par value per share	08/13/2025		S		2,749	D	$11.38	18,163	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

	/s/ Ciaran Long, as attorney-in-fact for Ilene Eskenazi	08/15/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Ilene Eskenazi report on the Form 4 for AKA?

The Form 4 reports a sale of 2,749 shares of A.K.A. Brands Holding Corp. common stock on 08/13/2025 at $11.38 per share, leaving 18,163 shares beneficially owned.

What is the relationship of the reporting person to AKA?

The reporting person, Ilene Eskenazi, is listed as a Director of A.K.A. Brands Holding Corp.

Were any derivative securities reported in this Form 4 for AKA?

No. The filing shows no derivative securities acquired, disposed of, or beneficially owned.

When was the Form 4 signed and by whom?

The Form 4 was signed on 08/15/2025 by /s/ Ciaran Long, as attorney-in-fact for Ilene Eskenazi.

Does the filing indicate a Rule 10b5-1 trading plan or amendment?

No. There is no indication in the disclosed fields that the transaction was made pursuant to a Rule 10b5-1 plan or that this filing is an amendment.